# Akari Therapeutics, Plc Posts Approximately $4.8 Million Q3 Net Loss

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/56981
Published: 2026-11-13T19:20:41.000Z
Updated: 2026-11-13T19:20:41.000Z
Section: Business

> The company’s third-quarter results cover the three months ended Sept. 30, 2026.

Akari Therapeutics, Plc (NASDAQ: AKTX) recorded an approximately $4.8 million net loss in its third-quarter 2026 financial results for the three months ended Sept. 30.